Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Disease × Bleomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 29 Lymphoma 17 Lymphoma, Large B-Cell, Diffuse 6 Lymphoma, Follicular 4 Vulvar Neoplasms 3 Testicular Neoplasms 3 Neoplasms, Germ Cell and Embryonal 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large-Cell, Immunoblastic 3 Seminoma 2 Ovarian Neoplasms 2 Neoplasms 2 Dendritic Cell Sarcoma, Interdigitating 2 Breast Neoplasms 2 Warts 1 Ulcer 1 Testicular Germ Cell Tumor 1 Teratoma 1 Stomach Neoplasms 1 Skin Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Processes 1 Ovarian Germ Cell Cancer 1 Neoplastic Processes 1 Neoplasms, Second Primary 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1

Interventions

Blood Specimen Collection 9 Surveys and Questionnaires 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 Prednisone 4 Colonoscopy 4 Biopsy, Fine-Needle 4 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Mammography 3 Magnetic Resonance Imaging 3 Liquid Biopsy 3 Lenalidomide 3 Interviews as Topic 3 Diagnostic Tests, Routine 3 Cyclophosphamide 3 weifuchun 2 pembrolizumab 2 obinutuzumab 2 Urination 2 Preoperative Exercise 2 Positron Emission Tomography Computed Tomography 2 Methods 2 Melphalan 2 Immunohistochemistry 2 Gemcitabine 2 Exercise 2 Educational Status 2 Doxorubicin 2 Dexamethasone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡